Anthony Hollenberg, MD

Highlights

1
The Journal of clinical investigation · 2020
RMRoy M Gulick AHAnthony Hollenberg
PMID: 32692726PMCID: PMC7456231DOISenior author8 citations

142

1 grant

PI
Hypothalamic regulation by thyroid hormone receptor phosphorylation
NIDDK · 2023–2027 · via NIH RePORTER
R01DK136661-05

Completed grants (9)

PI
Thyroid Follicular Cell Signaling and Development in Humans
National Institute of Diabetes and Digestive and Kidney Diseases · 2018–2023· 2 renewals
R01DK105029-07
PI
Corepressor regulation of nuclear receptor action
National Institute of Diabetes and Digestive and Kidney Diseases · 2018–2022· 3 renewals
R01DK056123-21S1
PI
Thyroid Hormone Signaling in Human Hepatocytes
National Institute of Diabetes and Digestive and Kidney Diseases · 2019–2022
R01DK117940-04
KP
Mechanisms of Hepatic Steatosis in Obesity and Type 2 Diabetes
American Diabetes Association · 2018–2019
1-17-PMF-007
PI
New Targets of Thyroid Hormone Action
National Institute of Diabetes and Digestive and Kidney Diseases · 2018–2019
R01DK098525-06
PI
Defining the thyroid hormone receptor Cistrome in vivo
NIDDK · 2011–2013 · via NIH RePORTER
R21DK091941-02
PI
Negative regulation by thyroid hormone
NIDDK · 2007–2012 · via NIH RePORTER
R01DK078090-03S1
PI
Corepressor Regulation of Nuclear Receptor Action
NIDDK · 2000–2010 · via NIH RePORTER
R56DK056123-10
PI
HYPOTHALAMIC SIGNALING BY LEPTIN AND THYROID HORMONE
NIDDK · 2000–2003 · via NIH RePORTER
R21DK057658-02

First-Year Medical Students Don White Coats During Historic Year
August 20, 2021
On Aug. 20, 106 students in Weill Cornell Medical College’s Class of 2025 received their short white coats during an outdoor, in-person White Coat Ceremony.
Dr. Laura Alonso Named Chief of the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center
September 6, 2019
Dr. Laura Alonso has been named chief of the Division of Endocrinology, Diabetes and Metabolism at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective Sept. 1. Dr. Alonso will also lead the Joan and Sanford I. Weill Center for Metabolic Health at Weill Cornell Medicine.
Dr. Manuel Hidalgo Named Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center
March 7, 2019
Dr. Manuel Hidalgo, a leading physician-scientist who specializes in pancreatic cancer and drug development, has been named chief of the Division of Hematology and Medical Oncology in the Weill Department of Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective June 1.

Llama Therapeutics, Inc.

Advance Medical · Elsevier, BV · UBC Late Stage, Inc